ArticleEuropean journal of nutrition2026
Long-term wholegrain intake in line with the Nordic Nutrition Recommendations 2023 and risk of breast cancer in a population-based cohort of women.
Article in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCurrent findings on the relationship between wholegrain intake and breast cancer are inconsistent. We aimed to estimate the association between long-term wholegrain intake and breast cancer risk, specifically investigating: (i) adherence to the updated Nordic Nutrition Recommendations (NNR2023) guidelines on wholegrain intake, and (ii) consumption of specific wholegrain products.
methodsData from food frequency questionnaires were used to assess adherence to NNR2023 guidelines on wholegrain intake and consumption of wholegrain products among 36,479 women (48-83 years) in the Swedish Mammography Cohort at two timepoints. Time-updated Cox proportional hazards regression models were used to estimate multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CI) for incident total breast cancer and hormone receptor-positive and -negative subtypes.
resultsDuring a mean follow-up of 16.5 years, 1,979 breast cancer cases were identified. Compared to long-term low adherence (< 50%, corresponding to < 45 g/day wholegrain intake), the HRs (95% CIs) for women with full adherence (≥ 90 g/day intake) were 0.78 (0.66, 0.94), 0.82 (0.67, 1.03), and 1.08 (0.65, 1.80), for total breast cancer, hormone receptor-positive, and hormone receptor-negative breast cancer, respectively. There was no clear association between long-term consumption of any specific wholegrain products and total breast cancer risk, although HRs for high oatmeal and for high breakfast cereal consumption were < 1, whilst HRs for high crispbread consumption were > 1.
conclusionWholegrain intake in line with NNR2023 was associated with a lower risk of total breast cancer. However, different wholegrain products may be differently associated with breast cancer risk, indicating the need for further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.